Abstract Details

Title Pharmacologic Characteristics of Valbenazine (NBI-98854) and its Metabolites

Topic Movement Disorders

Presentation(s) P2 - (-)

Poster/Presentation
Number 025

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
PRESENTER	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
	No disclosure on file
Scott Siegert	Mr. Siegert has received personal compensation for serving as an employee of Neurocrine Biosciences. Mr. Siegert has stock in Neurocrine Biosciences.

��ɫ����